Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by AdvanCell
AdvanCell Presents Updated Phase 1 Results on ADVC001 at ESMO 2026 with Encouraging Long-term Data
October 23, 2026
From
AdvanCell
Via
Business Wire
AdvanCell Appoints Sean Cassidy as Chief Financial Officer
September 15, 2026
From
AdvanCell
Via
Business Wire
AdvanCell to Present Updated Phase 1b Results from the TheraPb Trial at ESMO Congress 2026
July 21, 2026
From
AdvanCell
Via
Business Wire
AdvanCell Closes US $315 Million Oversubscribed Series D Financing to Advance Targeted Alpha Therapies and Expand Clinical and Commercial Manufacturing Infrastructure
July 15, 2026
From
AdvanCell
Via
Business Wire
AdvanCell Establishes U.S. Global Headquarters and Secures Flagship Manufacturing Facility in Greater Boston to Drive Growth Strategy
June 22, 2026
From
AdvanCell
Via
Business Wire
AdvanCell Strengthens Executive Leadership to Accelerate U.S. Expansion and Scale its Global Targeted Alpha Therapy Platform
June 08, 2026
From
AdvanCell
Via
Business Wire
AdvanCell Showcases Novel TheraPb Phase 2 Study Design of ADVC001 for the Treatment of Metastatic Prostate Cancer at ASCO GU Symposium 2026
February 24, 2026
From
AdvanCell
Via
Business Wire
AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal Cancer with Significant Medical Need
February 02, 2026
From
AdvanCell
Via
Business Wire
AdvanCell Receives First Delivery of High-Activity Thorium-228, Highlighting a Unique Industry Capability and Expertise Essential to Scaling Lead-212 Production for Targeted Alpha Therapies
December 08, 2025
From
AdvanCell
Via
Business Wire
AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer
December 02, 2025
From
AdvanCell
Via
Business Wire
AdvanCell to participate in Jefferies Global Healthcare Conference in London
November 11, 2025
From
AdvanCell
Via
Business Wire
AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer
October 21, 2025
From
AdvanCell
Via
Business Wire
AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer
October 18, 2025
From
AdvanCell
Via
GlobeNewswire
AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Directors
October 16, 2025
From
AdvanCell
Via
GlobeNewswire
AdvanCell to Present Promising Clinical Trial Results of ADVC001, a Novel Lead-212-based PSMA-targeted Alpha Therapy for Prostate Cancer, at ESMO 2025
October 12, 2025
From
AdvanCell
Via
Business Wire
AdvanCell Proudly Announces $18M in Federal Funding from the Medical Research Future Fund (MRFF) Frontiers Initiative for ‘Defeating Prostate Cancer with Targeted Alpha Therapy’
April 13, 2025
From
AdvanCell
Via
Business Wire
AdvanCell Enters Into Strategic Collaboration with Lilly to Advance Novel Targeted Alpha Therapies for the Treatment of Cancer
February 10, 2025
From
AdvanCell
Via
Business Wire
AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing
February 03, 2025
From
AdvanCell
Via
Business Wire
AdvanCell Expands Leadership Team with the Appointment of Christopher Horvath, MS MBA, as Chief Commercial Officer & Chief Operating Officer and Gary Li, PhD, as Chief Strategy Officer
May 08, 2024
From
AdvanCell
Via
Business Wire
AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer
January 04, 2024
From
AdvanCell
Via
Business Wire
AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer
November 07, 2023
From
AdvanCell
Via
Business Wire
AdvanCell Closes A$18M Series B Funding Led by Morningside
August 23, 2022
From
AdvanCell
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
